Clinical Trials Logo

Werner Syndrome clinical trials

View clinical trials related to Werner Syndrome.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05847179 Not yet recruiting - Werner Syndrome Clinical Trials

Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome

Start date: January 1, 2025
Phase: Phase 2
Study type: Interventional

This is a Phase 2, open-label study to A Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin for the Treatment of Bone Mineral Density (BMD) Loss in Subjects with Typical Werner Syndrome. There will be up to 5 subjects that will receive treatment with Progerinin twice daily for approximately 1 year.